COVID-19 cases are rising in more than half of states. Is the US in a summer wave? What to know about COVID trends and ...

No improvement in clinical outcomes occurred among inpatients with COVID-19 who received nirtmatrelvir-ritonavir or molnupiravir in addition to usual care.

Here are four high-yield blue-chip pharmaceutical stocks positioned to outperform and offer huge total return potential.

The interview with Dr Asad Khan on long Covid (Solidarity 747-748) highlights the contribution to the growth in mental ill-health of widespread long Covid, which affects hundreds of millions of ...